This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
05/29/15 - 12:23:25 PM ET (BATS BZX Real-time Price)
Div Yield: --
GNCA Day's Range
GNCA 52 Week Range
GNCA Business Summary
Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel vaccines and immunotherapies to treat infectious diseases.View GNCA key stats
Genocea Biosciences Inc - GNCA - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates Genocea Biosciences Inc as a
Sell with a ratings score of D.
Report Snippet: We rate GENOCEA BIOSCIENCES INC (GNCA) a SELL. This is driven by some concerns, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of the stocks we cover. The company's weaknesses can be seen in multiple areas, such as its feeble growth in its earnings per share, deteriorating net income and generally disappointing historical performance in the stock itself.